TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here's Why [Yahoo! Finance]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Yahoo! Finance
Royalty Pharma Plc (NASDAQ: RPRX ) is one of the best cheap biotech stocks to buy now . TD Cowen lifted the price target on Royalty Pharma Plc (NASDAQ:RPRX) to $50 from $45 on February 27, maintaining a Buy rating on the shares and telling investors that the company is poised to benefit from unique strengths, including differentiation from its competitors, growth of the biopharma royalty market, and the diversification of its portfolio. The firm thus updated its model to take into account these and other tailwinds. Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? Royalty Pharma Plc (NASDAQ:RPRX) also received a rating update from Goldman Sachs on February 12. The firm lifted the price target on the stock to $51 from $45 and reiterated a Buy rating on the shares. It told investors in a research note that Royalty Pharma Plc (NASDAQ:RPRX) reported solid fiscal Q4 results, with portfolio receipts and 2026 guidance surpassing expectations, implying 3%-8
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma Announces Expansion of Leadership TeamGlobeNewswire
- Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule [Yahoo! Finance]Yahoo! Finance
RPRX
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 144
- 3/2/26 - Form 144
- RPRX's page on the SEC website